Report Detail

Pharma & Healthcare Global Pet Pharmaceuticals Market Growth 2021-2026

  • RnM4284665
  • |
  • 08 February, 2021
  • |
  • Global
  • |
  • 166 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
  • 2.1.1 Global Pet Pharmaceuticals Consumption 2016-2026
  • 2.1.2 Pet Pharmaceuticals Consumption CAGR by Region
  • 2.2 Pet Pharmaceuticals Segment by Type
  • 2.2.1 Antiparasitic
  • 2.2.2 Biological Products
  • 2.2.3 Antibacterial
  • 2.2.4 Others
  • 2.3 Pet Pharmaceuticals Sales by Type
  • 2.3.1 Global Pet Pharmaceuticals Sales Market Share by Type (2016-2021)
  • 2.3.2 Global Pet Pharmaceuticals Revenue and Market Share by Type (2016-2021)
  • 2.3.3 Global Pet Pharmaceuticals Sale Price by Type (2016-2021)
  • 2.4 Pet Pharmaceuticals Segment by Application
  • 2.4.1 Prevention
  • 2.4.2 Treatment
  • 2.5 Pet Pharmaceuticals Sales by Application
  • 2.5.1 Global Pet Pharmaceuticals Sale Market Share by Application (2016-2021)
  • 2.5.2 Global Pet Pharmaceuticals Revenue and Market Share by Application (2016-2021)
  • 2.5.3 Global Pet Pharmaceuticals Sale Price by Application (2016-2021)
  • 3 Global Pet Pharmaceuticals by Company

    • 3.1 Global Pet Pharmaceuticals Sales Market Share by Company
    • 3.1.1 Global Pet Pharmaceuticals Sales by Company (2019-2021)
  • 3.1.2 Global Pet Pharmaceuticals Sales Market Share by Company (2019-2021)
  • 3.2 Global Pet Pharmaceuticals Revenue Market Share by Company
  • 3.2.1 Global Pet Pharmaceuticals Revenue by Company (2019-2021)
  • 3.2.2 Global Pet Pharmaceuticals Revenue Market Share by Company (2019-2021)
  • 3.3 Global Pet Pharmaceuticals Sale Price by Company
  • 3.4 Global Manufacturers Pet Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Pet Pharmaceuticals Product Location Distribution
  • 3.4.2 Players Pet Pharmaceuticals Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 Pet Pharmaceuticals by Region

    • 4.1 Global Pet Pharmaceuticals by Region
    • 4.1.1 Global Pet Pharmaceuticals Sales by Region
  • 4.1.2 Global Pet Pharmaceuticals Revenue by Region
  • 4.2 Americas Pet Pharmaceuticals Sales Growth
  • 4.3 APAC Pet Pharmaceuticals Sales Growth
  • 4.4 Europe Pet Pharmaceuticals Sales Growth
  • 4.5 Middle East & Africa Pet Pharmaceuticals Sales Growth
  • 5 Americas

    • 5.1 Americas Pet Pharmaceuticals Sales by Country
    • 5.1.1 Americas Pet Pharmaceuticals Sales by Country (2016-2021)
  • 5.1.2 Americas Pet Pharmaceuticals Revenue by Country (2016-2021)
  • 5.2 Americas Pet Pharmaceuticals Sales by Type
  • 5.3 Americas Pet Pharmaceuticals Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Pet Pharmaceuticals Sales by Region
    • 6.1.1 APAC Pet Pharmaceuticals Sales by Region (2016-2021)
  • 6.1.2 APAC Pet Pharmaceuticals Revenue by Region (2016-2021)
  • 6.2 APAC Pet Pharmaceuticals Sales by Type
  • 6.3 APAC Pet Pharmaceuticals Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Pet Pharmaceuticals by Country
    • 7.1.1 Europe Pet Pharmaceuticals Sales by Country (2016-2021)
  • 7.1.2 Europe Pet Pharmaceuticals Revenue by Country (2016-2021)
  • 7.2 Europe Pet Pharmaceuticals Sales by Type
  • 7.3 Europe Pet Pharmaceuticals Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Pet Pharmaceuticals by Country
    • 8.1.1 Middle East & Africa Pet Pharmaceuticals Sales by Country (2016-2021)
  • 8.1.2 Middle East & Africa Pet Pharmaceuticals Revenue by Country (2016-2021)
  • 8.2 Middle East & Africa Pet Pharmaceuticals Sales by Type
  • 8.3 Middle East & Africa Pet Pharmaceuticals Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Country
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends
  • 10 Marketing, Distributors and Customer

    • 10.1 Sales Channel
    • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
  • 10.2 Pet Pharmaceuticals Distributors
  • 10.3 Pet Pharmaceuticals Customer
  • 11 Global Pet Pharmaceuticals Market Forecast

    • 11.1 Global Pet Pharmaceuticals Forecast by Region
    • 11.1.1 Global Pet Pharmaceuticals Forecast by Regions (2021-2026)
  • 11.2.2 Global Pet Pharmaceuticals Revenue Forecast by Regions (2021-2026)
  • 11.2 Americas Forecast by Country
  • 11.3 APAC Forecast by Region
  • 11.4 Europe Forecast by Country
  • 11.5 Middle East & Africa Forecast by Country
  • 11.6 Global Pet Pharmaceuticals Forecast by Type
  • 11.7 Global Pet Pharmaceuticals Forecast by Application
  • 12 Key Players Analysis

    • 12.1 Zoetis
    • 12.1.1 Zoetis Company Information
  • 12.1.2 Zoetis Pet Pharmaceuticals Product Offered
  • 12.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.1.4 Zoetis Main Business Overview
  • 12.1.5 Zoetis Latest Developments
  • 12.2 Boehringer Ingelheim
  • 12.2.1 Boehringer Ingelheim Company Information
  • 12.2.2 Boehringer Ingelheim Pet Pharmaceuticals Product Offered
  • 12.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.2.4 Boehringer Ingelheim Main Business Overview
  • 12.2.5 Boehringer Ingelheim Latest Developments
  • 12.3 Merck
  • 12.3.1 Merck Company Information
  • 12.3.2 Merck Pet Pharmaceuticals Product Offered
  • 12.3.3 Merck Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.3.4 Merck Main Business Overview
  • 12.3.5 Merck Latest Developments
  • 12.4 Elanco
  • 12.4.1 Elanco Company Information
  • 12.4.2 Elanco Pet Pharmaceuticals Product Offered
  • 12.4.3 Elanco Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.4.4 Elanco Main Business Overview
  • 12.4.5 Elanco Latest Developments
  • 12.5 Virbac
  • 12.5.1 Virbac Company Information
  • 12.5.2 Virbac Pet Pharmaceuticals Product Offered
  • 12.5.3 Virbac Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.5.4 Virbac Main Business Overview
  • 12.5.5 Virbac Latest Developments
  • 12.6 Dechra Veterinary Products
  • 12.6.1 Dechra Veterinary Products Company Information
  • 12.6.2 Dechra Veterinary Products Pet Pharmaceuticals Product Offered
  • 12.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.6.4 Dechra Veterinary Products Main Business Overview
  • 12.6.5 Dechra Veterinary Products Latest Developments
  • 12.7 Ceva
  • 12.7.1 Ceva Company Information
  • 12.7.2 Ceva Pet Pharmaceuticals Product Offered
  • 12.7.3 Ceva Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.7.4 Ceva Main Business Overview
  • 12.7.5 Ceva Latest Developments
  • 12.8 Vetoquinol
  • 12.8.1 Vetoquinol Company Information
  • 12.8.2 Vetoquinol Pet Pharmaceuticals Product Offered
  • 12.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.8.4 Vetoquinol Main Business Overview
  • 12.8.5 Vetoquinol Latest Developments
  • 12.9 Ouro Fino Saude
  • 12.9.1 Ouro Fino Saude Company Information
  • 12.9.2 Ouro Fino Saude Pet Pharmaceuticals Product Offered
  • 12.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.9.4 Ouro Fino Saude Main Business Overview
  • 12.9.5 Ouro Fino Saude Latest Developments
  • 12.10 Norbrook
  • 12.10.1 Norbrook Company Information
  • 12.10.2 Norbrook Pet Pharmaceuticals Product Offered
  • 12.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.10.4 Norbrook Main Business Overview
  • 12.10.5 Norbrook Latest Developments
  • 12.11 Jindun
  • 12.11.1 Jindun Company Information
  • 12.11.2 Jindun Pet Pharmaceuticals Product Offered
  • 12.11.3 Jindun Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.11.4 Jindun Main Business Overview
  • 12.11.5 Jindun Latest Developments
  • 12.12 Chopperlvya Animal Health
  • 12.12.1 Chopperlvya Animal Health Company Information
  • 12.12.2 Chopperlvya Animal Health Pet Pharmaceuticals Product Offered
  • 12.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.12.4 Chopperlvya Animal Health Main Business Overview
  • 12.12.5 Chopperlvya Animal Health Latest Developments
  • 12.13 CAHIC
  • 12.13.1 CAHIC Company Information
  • 12.13.2 CAHIC Pet Pharmaceuticals Product Offered
  • 12.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2021)
  • 12.13.4 CAHIC Main Business Overview
  • 12.13.5 CAHIC Latest Developments
  • 13 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Pet Pharmaceuticals will have significant change from previous year. By the most conservative estimates of global Pet Pharmaceuticals market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 13110 million in 2020. Over the next five years the Pet Pharmaceuticals market will register a 7.3% CAGR in terms of revenue, the global market size will reach US$ 17380 million by 2026.
    This report presents a comprehensive overview, market shares, and growth opportunities of Pet Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

    Antiparasitic

    Biological Products

    Antibacterial

    Others

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

    Prevention

    Treatment

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

    Zoetis

    Boehringer Ingelheim

    Merck

    Elanco

    Virbac

    Dechra Veterinary Products

    Ceva

    Vetoquinol

    Ouro Fino Saude

    Norbrook

    Jindun

    Chopperlvya Animal Health

    CAHIC


    Summary:
    Get latest Market Research Reports on Pet Pharmaceuticals. Industry analysis & Market Report on Pet Pharmaceuticals is a syndicated market report, published as Global Pet Pharmaceuticals Market Growth 2021-2026. It is complete Research Study and Industry Analysis of Pet Pharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,523.92
    5,047.84
    2,924.63
    5,849.27
    378,717.50
    757,435.00
    255,622.50
    511,245.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report